Assignee
SUMITOMO DAINIPPON PHARMA CO LTD
JP·66 granted patents·55 pending applications·143 citations·filing 2013–2021
Top patents by PatentIndex Score
121 records- 0194US9376398B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2013·Granted Jun 28, 2016·35 cites·30 claims
- 0293US9248173B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Feb 2, 2016·14 cites·28 claims
- 0392US10632192B2Pyrimidine compounds and their use as vaccine adjuvantsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Apr 28, 2020·6 cites·25 claims
- 0492US9181302B2WT1 antigen peptide conjugate vaccineSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Nov 10, 2015·17 cites·21 claims
- 0591US10815241B2Optically active azabicyclo ring derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Oct 27, 2020·4 cites·10 claims
- 0691US10807993B2Dihydrochromene derivativesSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Oct 20, 2020·3 cites·28 claims
- 0790US11339151B2Aliphatic acid amide derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2021·Granted May 24, 2022·2 cites·8 claims
- 0888US11352366B22-aminoquinazolinone derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2021·Granted Jun 7, 2022·1 cites·12 claims
- 0986US11214772B2Production method for retinal tissueSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Jan 4, 2022·5 cites·47 claims
- 1086US10800755B22,6-disubstituted pyridine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Oct 13, 2020·2 cites·4 claims
- 1185US11369605B2Optically active azabicyclo ring derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted Jun 28, 2022·5 cites·39 claims
- 1285US10758535B1Therapeutic drug for dyskinesiaSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted Sep 1, 2020·3 cites·20 claims
- 1385US9884045B2Transplantation adjuvant in cell therapy using neural progenitor cellsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2013·Granted Feb 6, 2018·6 cites·19 claims
- 1484US11214771B2Production method for nerve tissueSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Jan 4, 2022·3 cites·27 claims
- 1584US10150743B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Dec 11, 2018·4 cites·19 claims
- 1683US11325921B2Optically active crosslinked cyclic secondary amine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted May 10, 2022·2 cites·23 claims
- 1783US9828362B21,4-disubstituted imidazole derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Nov 28, 2017·5 cites·14 claims
- 1881US10183913B2Pyrazole compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted Jan 22, 2019·2 cites·28 claims
- 1979US10034880B2Ophthalmic suspension formulationSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Jul 31, 2018·2 cites·24 claims
- 2078US10745401B2Condensed lactam derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Aug 18, 2020·1 cites·4 claims
- 2178US10329267B2Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dioneSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Jun 25, 2019·2 cites·36 claims
- 2278US10260068B2Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressivaSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Apr 16, 2019·3 cites·26 claims
- 2377US10703755B2Substituted purine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Jul 7, 2020·2 cites·27 claims
- 2477US9688670B2Benzimidazole compounds and medical uses thereofSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Jun 27, 2017·2 cites·23 claims
- 2575US11253476B2Vaccine adjuvant formulationSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted Feb 22, 2022·1 cites·15 claims
- 2674US10870642B2Biheterocyclic compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted Dec 22, 2020·0 cites·34 claims
- 2773US10588952B2Conjugate vaccine using trimming function of ERAP1SUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Mar 17, 2020·2 cites·8 claims
- 2872US10723703B2Pyrazole compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted Jul 28, 2020·0 cites·2 claims
- 2972US9555027B2Pharmaceutical compositionSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Jan 31, 2017·1 cites·34 claims
- 3071US11312688B2Pyrazole compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Apr 26, 2022·0 cites·7 claims
- 3171US9907794B2Pharmaceutical compositionSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2015·Granted Mar 6, 2018·1 cites·30 claims
- 3270US11266738B2Substituted pyrimidines as vaccine adjuvantsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Mar 8, 2022·0 cites·5 claims
- 3370US10807945B21,4-disubstituted imidazole derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Oct 20, 2020·1 cites·27 claims
- 3470US9732065B2Cyclic aminomethyl pyrimidine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Aug 15, 2017·3 cites·20 claims
- 3569US10611746B2Method for producing 2-acetyl-4H,9H-naphtho[2,3-B]furan-4,9-dioneSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Granted Apr 7, 2020·0 cites·41 claims
- 3669US9718840B2Condensed 5-oxazolidinone derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Granted Aug 1, 2017·3 cites·31 claims
- 3768US10875835B2Method for producing 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dioneSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Dec 29, 2020·0 cites·19 claims
- 3867US2021070724A1Method for producing 2-acetyl-4h,9h-naphtho[2,3-b]furan-4,9-dioneSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3966US10953008B2Substituted pyrazolo[1,5-a]pyrazines as negative allosteric modulators of group II metabotropic glutamate receptorSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Mar 23, 2021·0 cites·19 claims
- 4065US11299465B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Apr 12, 2022·0 cites·18 claims
- 4165US10562861B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted Feb 18, 2020·0 cites·13 claims
- 4265US10323024B2Biheterocyclic compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Jun 18, 2019·0 cites·28 claims
- 4362US10087146B2Pyrazole compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2017·Granted Oct 2, 2018·0 cites·3 claims
- 4462US2022062421A1Transdermal cancer antigen peptide preparationSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 4562US2019254976A1Medicament-containing hollow particleSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 4661US11014905B22,6-disubstituted pyridine derivativeSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted May 25, 2021·0 cites·24 claims
- 4761US2019022091A1Method of treatment for mental disordersSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 4860US11066425B1Oxo-substituted compoundSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Jul 20, 2021·0 cites·27 claims
- 4960US2018161322A1Pharmaceutical compositionSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 5058US10098875B2Method of treatment for mental disordersSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Oct 16, 2018·0 cites·8 claims
Showing the top 50 of 121 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SUMITOMO DAINIPPON PHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →